powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1104244813
Farah Nasraty
Hematology-Oncology
La Jolla,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 050077
Hospital
CCN 050324
Hospital
CCN 050424
Hospital
CCN 050503
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,791
Unique beneficiaries
—
Total services
155,234
Distinct HCPCS
59
Medicare payment
$2.0M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — top quintile (cohort median 4,173).
PRESCRIBING · PART D · 2024
Total Rx claims
1,227
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
17
Brand share
11.2%
Top prescribed drugs
Anastrozole
607 claims
Letrozole
152 claims
Exemestane
85 claims
Tamoxifen Citrate
79 claims
Prochlorperazine Maleate
43 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
57
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K